Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/44764, first published
.

Journals
- Akbar K, Passaro A, Di Gioia M, Martini E, Dragone M, Zullo A, Stasolla F. Reviewing the Horizon: The Future of Extended Reality and Artificial Intelligence in Neurorehabilitation for Brain Injury Recovery. Information 2024;15(8):501 View
- Rice D, Ozolins C, Biswas R, Almesfer F, Zeng I, Parikh A, Vile W, Rashid U, Graham J, Kluger M. Home-based EEG Neurofeedback for the Treatment of Chronic Pain: A Randomized Controlled Clinical Trial. The Journal of Pain 2024;25(11):104651 View
- Hosono T, Niwa Y, Kondoh M. Comparison of Product Features and Clinical Trial Designs for the DTx Products with the Indication of Insomnia Authorized by Regulatory Authorities. Therapeutic Innovation & Regulatory Science 2024;58(6):1138 View
- Noda Y, Nomura A. Digital Therapeutics for Nicotine Dependence. Journal of Asian Pacific Society of Cardiology 2025;4 View
- Sharp G, Dwyer B, Randhawa A, McGrath I, Hu H. The Effectiveness of a Chatbot Single-Session Intervention for People on Waitlists for Eating Disorder Treatment: Randomized Controlled Trial. Journal of Medical Internet Research 2025;27:e70874 View
- Catalogna M, Saporta N, Nathansohn-Levi B, Tamir T, Shahaf A, Molcho S, Erlich S, Shelly S, Amedi A. Mobile application leads to psychological improvement and correlated neuroimmune function change in subjective cognitive decline. npj Digital Medicine 2025;8(1) View
- Roth L, Steckhan N, Schwarz P. Impact of a digital application on HbA1c levels in people with diabetes: a randomized controlled trial. Frontiers in Digital Health 2025;7 View
- Mukai K, Kyosuke Y, Ogino S, Hosoi Y, Hayashida K, Matsunaga H. Benefits and barriers associated with using cognitive–behavioral therapy to treat obsessive–compulsive disorder: a narrative review. Frontiers in Psychiatry 2025;16 View
- Lee S, Park K, Lee D, Choi E, Lee Y, Lee E. Impact of Adherence to Digital Cognitive Behavioral Therapy for Insomnia Effectiveness. Yonsei Medical Journal 2025;66(10):657 View
- Hosono T, Tsutsumi R, Niwa Y, Kondoh M. Magnitude of the Digital Placebo Effect and Its Moderators on Generalized Anxiety Symptoms: Systematic Review and Meta-Analysis. Journal of Medical Internet Research 2025;27:e74905 View
- Gallegos K, Potter J, King V, Siegel G, Siegel L, Marino E. Development of a Sham Smartphone App for Opioid Use Disorder: Acceptability and Suitability Study. JMIR Formative Research 2025;9:e71105 View
- Park K, Lee S, Lee Y, Moon D, Lee E. Validating the Efficacy of a Mobile Digital Therapeutic for Insomnia (WELT-I): Randomized Controlled Decentralized Clinical Trial. Journal of Medical Internet Research 2025;27:e70722 View
- YANG J, QIN Y, WANG S, WU Q, WANG J, LI H, WU E, HUANG T, ZENG D, SHENG B. Extended reality in neurology: Technological analysis and clinical value. SCIENTIA SINICA Technologica 2025;55(10):1674 View
- Huneke N, Bolea-Alamañac B. Toward rigorous control conditions in trials of digital therapeutics. European Neuropsychopharmacology 2025;101:1 View
- Sze W, Waki K, Lane D, Hasegawa K, Nakada R, Iwata S, Ji Y, Isogawa A, Aoyama T, Miyake K, Kadowaki Y, Kawaguchi T, Matsuo Y, Miyoshi K, Ishibashi N, Toda G, Kameda S, Igarashi M, Tanaka M, Yamauchi T, Nangaku M. Efficacy of FiberMore, an AI-Based mHealth Intervention to Increase Dietary Fiber Intake Among Type 2 Diabetes Patients: Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols 2025;14:e78019 View
Books/Policy Documents
- Mandiello A, Franzese G. Advanced Perspectives and Trends in Digital Transformation of Firms, Networks, and Society. View
